Acute Leukemia

August 14, 2018

Relapsed Acute Myeloid Leukemia

Charles H. Weaver, MD
August 14, 2018

Treatment of Childhood Acute Lymphoblastic Leukemia

Charles H. Weaver, MD
December 22, 2017

Novel Agent may Reverse Resistance to Targeted Therapy in Acute Leukemia and MDS

Charles H. Weaver, MD
September 1, 2017

FDA Approves First Gene Therapy

Charles H. Weaver, MD
August 22, 2017

Besponsa for B-cell Acute Lymphoblastic Leukemia

Charles H. Weaver, MD
May 10, 2017

FDA Approves Rydapt for Treatment of Acute Myeloid Leukemia

Charles H. Weaver, MD
November 14, 2016

Childhood Acute Lymphoblastic Leukemia: Screening/Prevention

Charles H. Weaver, MD
September 26, 2016

Rituxan Improves Survival in Young Adults with Acute Lymphoblastic Leukemia

Charles H. Weaver, MD
August 9, 2016

Pracinostat Receives Designation from FDA for Treatment with Newly Diagnosed AML

Charles H. Weaver, MD
July 4, 2016

GlycoMimetics Receives FDA Designation for Treatment of Acute Myeloid Leukemia

Charles H. Weaver, MD
March 30, 2016

Vyxeos™ Improves Survival for Elderly in AML

Charles H. Weaver, MD
December 16, 2015

Addition of Rituxan Improves Outcomes in Some Acute Lymphoblastic Leukemias

Charles H. Weaver, MD